Butterfly, Graham, Wise Equity target nutraceuticals; Demand for antimicrobial testing drives Astorg’s $1bn carve-out of Thermo Fishers’ microbiology biz
Butterfly Equity, Graham Partners and Wise Equity are among the firms transacting with nutraceuticals assets.
14 August 2026•4 mins read
